PT-141 + Melanotan II Stack (10 mg Vials) Dosage Protocol

Also known as: Bremelanotide + MT-II Stack

Sexual function support and pigmentation enhancement, used together.

Dose range
PT-141: 750-1750 mcg on-demand; Melanotan II: 250-1000 mcg daily
Route
Subcutaneous
Frequency
PT-141: On-demand (max 1x/24h); Melanotan II: Once daily (loading), then 2-3x/week (maintenance)
Cycle length
8-16 weeks (example protocol)

This protocol outlines the combined use of PT-141 and Melanotan II peptides. PT-141 is used on-demand for sexual function, while Melanotan II is dosed daily for skin pigmentation and other related effects, with specific guidance for reconstitution and administration.

  • Both peptides target melanocortin receptors for distinct effects.
  • PT-141 is primarily for sexual function, Melanotan II for pigmentation and sexual function.
  • Reconstitute each 10 mg vial with 3.0 mL of bacteriostatic water.
  • Always titrate doses, especially for Melanotan II, to assess tolerance.
  • Rotate injection sites (abdomen, thighs, upper arms) to minimize irritation.

Reconstitution

Vial strength

10 mg

Bacteriostatic water

3 mL

Concentration

3.33 mg/mL

1 unit = 0.01 mL = 33.3 mcg (on a U-100 syringe)

  1. 1Draw 3.0 mL of bacteriostatic water using a sterile syringe.
  2. 2Slowly inject the water down the inner wall of the peptide vial to avoid direct impact on the powder and prevent foaming.
  3. 3Gently swirl or roll the vial until all powder is fully dissolved; do not shake.
  4. 4Label the reconstituted vial with the date, peptide name, and concentration.
  5. 5Store the reconstituted solution in the refrigerator, protected from light.

Dosing schedule

PhaseDoseOn a U-100 syringe
PT-141 Initial/Titration500-750 mcg15-22 units (0.15-0.22 mL)
PT-141 Standard1000-1500 mcg30-45 units (0.30-0.45 mL)
PT-141 Full/FDA-Approved1750 mcg52 units (0.52 mL)
Melanotan II Week 1250 mcg daily7.5 units (0.075 mL)
Melanotan II Week 2500 mcg daily15 units (0.15 mL)
Melanotan II Weeks 3-4750 mcg daily22 units (0.22 mL)
Melanotan II Weeks 5+ (Loading)1000 mcg daily30 units (0.30 mL)
Melanotan II Maintenance500-1000 mcg (2-3x/week)15-30 units (0.15-0.30 mL)

Protocol detail

PT-141 DosingStart with 500-750 mcg and gradually increase to 1750 mcg as tolerated. Use on-demand, with a maximum of 8 doses per month and no more than one dose every 24 hours.
Melanotan II DosingBegin at 250 mcg daily and increment by 250 mcg every 5-7 days until reaching the target of 1000 mcg. Adjust to a maintenance schedule once desired effects are achieved.
TimingAdminister PT-141 at least 45 minutes prior to anticipated activity. Melanotan II can be injected at any consistent time each day.
Injection SitesFor both peptides, alternate injection sites between the abdomen and thighs to prevent localized irritation.

Overview at a glance

PT-141On-demand subcutaneous use for enhancing sexual function; typically 1.75 mg administered at least 45 minutes before activity.
Melanotan IIDaily subcutaneous injections during an initial loading phase (4-8 weeks), then transitioning to 2-3 times weekly for maintenance of pigmentation and related effects.
ReconstitutionBoth peptides require reconstitution with 3.0 mL of bacteriostatic water per 10 mg vial, resulting in a concentration of approximately 3.33 mg/mL.
StorageLyophilized form is stored frozen at -20 °C (-4 °F); once reconstituted, store in the refrigerator at 2-8 °C (35.6-46.4 °F).

How it works

PT-141 (bremelanotide) and Melanotan II are both synthetic melanocortin receptor agonists. PT-141 specifically acts on central nervous system melanocortin receptors (MC3R and MC4R) to influence sexual function, being FDA-approved for hypoactive sexual desire disorder. Melanotan II also targets these receptors but, in addition to sexual function, significantly stimulates melanocytes, leading to increased melanin production and skin pigmentation. This dual action allows for combined benefits, with PT-141 focusing on desire and Melanotan II on tanning and continued sexual support.

Reported effects

  • Enhanced sexual desire and function (PT-141 & Melanotan II)
  • Increased skin pigmentation and tanning (Melanotan II)
  • Reduced distress from low libido (PT-141)

Reported side effects

  • Nausea (common with initial doses)
  • Facial flushing
  • Headache
  • Injection-site reactions
  • Temporary blood pressure increase (PT-141)
  • Appetite suppression (Melanotan II)
  • Darkening of existing moles (Melanotan II)

Storage

Lyophilised (unmixed)

Store at -20 °C (-4 °F) in dry, dark conditions. PT-141 shows short-term room-temperature stability (approx. 3 weeks).

After reconstitution

Refrigerate at 2-8 °C (35.6-46.4 °F); use within approximately 1 week for optimal potency. Avoid repeated freeze-thaw cycles.

Supplies

Peptide vialsPT-141 (10 mg) and Melanotan II (10 mg) vials based on desired cycle length (e.g., 2-4 PT-141 vials and 6-12 Melanotan II vials for 8-16 weeks).
Insulin syringesU-100 insulin syringes (e.g., 8-16 syringes for PT-141; 56-112 syringes for Melanotan II over 8-16 weeks).
Bacteriostatic water10 mL bottles (e.g., 1-2 bottles for PT-141; 2-4 bottles for Melanotan II over 8-16 weeks).
Alcohol swabsMultiple boxes for sanitation (two per injection: one for vial, one for skin).

Important notes

  • Use a new sterile insulin syringe for each injection and dispose of it properly in a sharps container.
  • Rotate injection sites to prevent localized irritation and promote absorption.
  • Inject slowly and steadily; wait a few seconds before withdrawing the needle.
  • Document each dose, time, and injection site for consistency and monitoring.
  • For Melanotan II, controlled UV exposure can enhance pigmentation but always use sun protection.

Frequently asked questions

Can I use PT-141 and Melanotan II together for both libido and tanning?

Yes, this protocol combines both peptides to leverage PT-141's primary effect on sexual desire and Melanotan II's ability to induce skin pigmentation, alongside its own effects on sexual function. It's important to follow the distinct dosing schedules for each.

What's the best way to handle potential nausea from these peptides?

Nausea is a common initial side effect for both peptides. Starting with a lower dose and gradually titrating up can help the body adjust. Administering the peptide with food or before bed for Melanotan II might also reduce discomfort for some individuals.

How long does it take to see results from Melanotan II, and how should I manage UV exposure?

Melanotan II results for pigmentation typically become noticeable within 2-4 weeks of daily loading. Controlled, gradual exposure to UV light (from the sun or tanning beds) can enhance the tanning effect, but always use appropriate sun protection to prevent skin damage.

What is the maximum number of PT-141 doses I can take in a month?

For PT-141, it is recommended not to exceed 8 doses per month and to ensure at least 24 hours pass between doses. This spacing helps manage potential side effects and aligns with observed clinical guidelines.

Educational reference only. These figures summarise how PT-141 + Melanotan II Stack is commonly described in research literature and supplier documentation, including the PT-141 + Melanotan II Stack listing at peptidesuk4u.co.uk. They are not a prescription, not medical advice, and not a recommendation to self-administer anything.

Related protocols

Back to all protocols